A Novel Erythropoiesis Stimulating Protein (NESP; Darbopoetin Alfa) for the Treatment of Anemia in Lung Cancer Patients Receiving Multi-cycle Platinum-Containing Chemotherapy
Clinical trial NCT03776032 · COMPLETED
Trial details
- NCT number
- NCT03776032
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1999-09-14
- Primary completion
- 2000-11-08
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.